ArticleThe lancet. Gastroenterology & hepatology2020

Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study.

Akbar K Waljee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.